Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First Three Quarters of 2025 SHANGHAI, Oct.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback